SNDX Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications.

$19.14  -0.43 (-2.20%)
As of 06/18/2021 15:59:52 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/03/2016
Outstanding shares:  48,248,559
Average volume:  441,400
Market cap:   $944,224,300
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    87164F105
ISIN:        US87164F1057
Sedol:      BN7Q7R7
Valuation   (See tab for details)
PE ratio:   -10.83
PB ratio:   4.07
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy